Provided by Tiger Trade Technology Pte. Ltd.

MediWound

15.05
-0.6600-4.20%
Post-market: 15.050.00000.00%19:07 EDT
Volume:123.21K
Turnover:1.87M
Market Cap:192.96M
PE:-7.17
High:16.12
Open:15.72
Low:14.94
Close:15.71
52wk High:22.51
52wk Low:14.14
Shares:12.82M
Float Shares:9.17M
Volume Ratio:1.36
T/O Rate:1.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0990
EPS(LYR):-2.0990
ROE:-63.86%
ROA:-19.77%
PB:4.42
PE(LYR):-7.17

Loading ...

Mediwound Ltd: Company Reaffirms Its Revenue Guidance of $24-26 Mln for 2026, $32-35 Mln for 2027, and $50-55 Mln for 2028

THOMSON REUTERS
·
Mar 05

MediWound Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire
·
Mar 05

Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD) and Veeva Systems (VEEV)

TIPRANKS
·
Mar 05

MediWound management to meet with Maxim

TIPRANKS
·
Mar 03

Mediwound Ltd expected to post a loss of 63 cents a share - Earnings Preview

Reuters
·
Mar 03

MediWound Ltd. Held Extraordinary Shareholder Meeting

Reuters
·
Feb 20

MediWound Ltd. Updates Financial Calendar

Reuters
·
Feb 19

Press Release: MediWound to Report Fourth Quarter and Full Year 2025 Financial Results

Dow Jones
·
Feb 19

MediWound to Present at Upcoming Investor Conferences

GlobeNewswire
·
Feb 17

FDA aware of Integra recommending removal of MediWound, CVS Wound Gel products

TIPRANKS
·
Jan 23

MediWound Ltd. Shareholders to Vote on 300,000 Share Increase for 2024 Incentive Plan at Upcoming Meeting

Reuters
·
Jan 21

MediWound Calls February 19, 2026 Extraordinary Meeting to Expand 2024 Share Incentive Plan

TIPRANKS
·
Jan 16

Analysts Offer Insights on Healthcare Companies: Nuvation Bio (NUVB), Mediwound (MDWD) and Argenx Se (ARGX)

TIPRANKS
·
Jan 13

MediWound Shares Fall on Cut to 2025 Revenue Outlook

Dow Jones
·
Jan 12

MediWound Showcases Next-Generation Enzymatic Therapies for Non-Surgical Tissue Repair

Reuters
·
Jan 12

MediWound Projects Revenue to Reach $50-55 Million by 2028

Reuters
·
Jan 12

MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference

GlobeNewswire
·
Jan 12

MediWound Study Finds NexoBrid Removes Over 90% of Traumatic Tattoo Pigments After Injuries

Reuters
·
Dec 10, 2025

MediWound: Strong Financial Health and Market Opportunities Drive Buy Rating

TIPRANKS
·
Nov 23, 2025

MediWound Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Nov 21, 2025